TY  - CONF
A1  - Neef, Vanessa
A1  - König, Sven
A1  - Monden, Daniel
A1  - Ronellenfitsch, Michael Wilfried
A1  - Harter, Patrick Nikolaus
A1  - Senft, Christian
A1  - Meybohm, Patrick
A1  - Hattingen, Elke
A1  - Zacharowski, Kai
A1  - Seifert, Volker
A1  - Baumgarten, Peter
T1  - Impact and risk factors of red blood cell transfusion on patients undergoing elective primary meningioma resection
T2  - Brain and Spine
N2  - Background: Transfusion of red blood cells (RBC) in patients undergoing major elective cranial surgery is associated with increased morbidity, mortality and prolonged hospital length of stay (LOS). This retrospective single center study aims to identify the impact of RBC transfusions on skull-base and non-skull-base meningioma patients including the identification of risk factors for RBC transfusion.
Methods: From October 2009 - October 2016 we retrospectively analyzed 423 primary meningioma patients undergoing surgery for primary meningioma resection our department.
Results: Of these 423 patients, 68 (16.1%) received RBC transfusion and 355 (83.9%) did not receive RBC units. Preoperative anaemia rate was significantly higher in transfused patients (17.7%) compared to patients without RBC transfusion (6.2%; p = 0.0015). In transfused patients, postoperative complications as well as hospital LOS was significantly higher (p < 00001) compared to non-transfused patients. After multivariate analyses, risk factors for RBC transfusion were preoperative American Society of Anesthesiologists (ASA) physical status score (p = 0.0247), tumor size (p = 0.0006), surgical time (p = 0.0018) and intraoperative blood loss (p < 0.001). Kaplan-Meier curves revealed significant influence on overall survival by preoperative anaemia, RBC transfusion, smoking, cardiovascular disease, preoperative KPS ≤ 60% and age (elderly ≥ 75 years).
Conclusion: We concluded that blood loss due to large tumors or localization near large vessels are the main triggers for RBC transfusion in meningioma patients paired with a potential preselection that masks the effect of preoperative anaemia in multivariate analysis. Further studies evaluating the impact of preoperative anaemia management for reduction of RBC transfusion are needed to improve clinical outcomes of meningioma patients.
Y1  - 2021
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/77924
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-779248
SN  - 2772-5294
VL  - 1
IS  - Supplement 2, 100568
PB  - Elsevier
CY  - Amsterdam
ER  -